In breast cancer (BRCA), DDB2 mRNA was enriched in ER-positive tumors within The Cancer Genome Atlas (TCGA) and GSE50948 datasets (Figure 1E), particularly in luminal subtypes (Figure 1F). Here, DDB2 is linked to breast carcinoma.